Company Quick10K Filing
Ocean Bio Chem
Price3.27 EPS0
Shares9 P/E11
MCap31 P/FCF19
Net Debt0 EBIT4
TEV31 TEV/EBIT8
TTM 2019-09-30, in MM, except price, ratios
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-03-30
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-05-13 Filed 2010-05-13
10-K 2009-12-31 Filed 2010-03-30
8-K 2020-05-29
8-K 2020-05-26
8-K 2020-05-15
8-K 2020-04-27
8-K 2020-04-27
8-K 2020-03-19
8-K 2020-01-28
8-K 2019-11-14
8-K 2019-08-14
8-K 2019-06-03
8-K 2019-03-22
8-K 2018-11-14
8-K 2018-08-31
8-K 2018-08-14
8-K 2018-08-06
8-K 2018-05-18
8-K 2018-05-15
8-K 2018-04-26
8-K 2018-03-30
8-K 2018-03-19
8-K 2018-01-17

OBCI 8K Current Report

Item 5.07. Submission of Matters To A Vote of Security Holders

Ocean Bio Chem Report 2018-05-18

8-K 1 f8k051818_oceanbiochem.htm CURRENT REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

Form 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 18, 2018

 

OCEAN BIO-CHEM, INC.

(Exact name of registrant as specified in charter)

 

Florida   0-11102   59-1564329
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   I.R.S. Employer
Identification No.)

 

4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314

(Address of principal executive offices) (Zip Code)

 

(954) 587-6280

Registrant’s telephone number, including area code:

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company      ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐

 

 

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders

 

Ocean Bio-Chem, Inc. (the “Company”) held its Annual Meeting of Stockholders on May 18, 2018. The proposals submitted by the Board of Directors to a vote of the shareholders, and the results of the voting on each proposal, are noted below.

 

Proposal No. 1 — Election of Directors.

 

The following nominees were elected by the shareholders to serve on the Company’s Board of Directors until the next annual meeting of shareholders or until their respective successors have been duly elected and qualified:

 

Nominees   For     Withhold     Broker
Non-Votes
 
Jeffrey S. Barocas     6,621,606       307,941       2,263,031  
Diana Mazuelos Conard     6,857,741       71,806       2,263,031  
Gregor M. Dornau     6,671,074       258,473       2,263,031  
Peter G. Dornau     6,671,074       258,473       2,263,031  
William W. Dudman     6,671,074       258,473       2,263,031  
James M. Kolisch     6,661,071       268,473       2,263,031  
Kimberly A. Krause     6,867,741       61,806       2,263,031  
John B. Turner     6,857,491       72,056       2,263,031  

  

Proposal No. 2 — Ratification of the Appointment of Independent Registered Public Accounting Firm.

 

The shareholders ratified the appointment of Accell Audit & Compliance, PA as the Company's independent registered public accounting firm for 2018. The voting results were as follows:

 

For   Against   Abstain   Broker Non-Votes 
                  
 6,031,643    -    -    2,263,031 

 

Proposal No. 3 — Advisory Vote on the Compensation of our Named Executive Officers;

 

The shareholders approved, on an advisory basis, the compensation of our named executive officers. The voting results were as follows.

 

For   Against   Abstain   Broker Non-Votes 
 6,903,266    24,990    1,291    2,325,033 

 

 1 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  OCEAN BIO-CHEM, INC.
     
Date: May 23, 2018 By: /s/ Jeffrey S. Barocas
    Jeffrey S. Barocas
    Chief Financial Officer

 

 

2